To test if the effect of glucose metabolism suppression on anti‐PD‐L1 immunotherapy could be replicated in another mouse model, we used C57BL/6 mice with subcutaneous MC38 shCtrl or shEDEM3 tumours (Figure 8C). The gene discussed is CD274; the disease is neoplasm.